Meeting
2015 ASCO Annual Meeting
A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.
Authors
Federico Innocenti
The University of North Carolina at Chapel Hill, Chapel Hill, NC
Federico Innocenti , Kouros Owzar , Chen Jiang , Alexander Sibley , Donna Niedzwiecki , Heinz-Josef Lenz , Monica M. Bertagnolli , Paula N. Friedman , Yoichi Furukawa , Michiaki Kubo , Mark J. Ratain , Charles David Blanke , Alan P. Venook , Howard L. McLeod
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT00265850
Citation
J Clin Oncol 33, 2015 (suppl; abstr 3599)
DOI
10.1200/jco.2015.33.15_suppl.3599
Abstract #
3599
Poster Bd #
92
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
CEA response and depth of response (DpR) to predict clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line cetuximab plus oxaliplatin-based chemotherapy: A sub-analysis of the JACCRO CC-05/06 trials.
First Author: Yu Sunakawa
Poster
2012 Gastrointestinal Cancers Symposium
Early outcome of a phase I study of interrupted pulse dosed axitinib combined with FOLFOX or FOLFIRI in refractory metastatic colorectal cancer.
First Author: Eric Roeland
Poster
2011 ASCO Annual Meeting
The predictive value of single nucleotide polymorphisms in the vascular endothelial growth factor system in patients with metastatic colorectal cancer treated with bevacizumab plus chemotherapy as first-line treatment: Results of the phase III ACT trial NCT00598156 translational study.
First Author: T. Hansen
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effectiveness of biologic agents among Hispanics in the US with metastatic colorectal cancer.
First Author: Riya Jayesh Patel